Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • The Centrum Hotel unveils a Pickleball Arena, a game-changer for sports enthusiasts and tourists Business
  • ASUS Exclusive Store Opens in Kukatpally, Hyderabad; Operated by Laptop Store Business
  • Galgotias University Holds 10th Convocation Ceremony; Leaders Emphasise Resilience, Discipline, and Lifelong Learning Education
  • DPS Bharuch Creates History as the District’s First School to Implement The Mind Sync – India’s First Mental Health Education Program Lifestyle
  • Meet the 10 Iconic Brands Reshaping Industries & Inspiring Growth in 2023 Business
  • Core4 Engineers Limited Files DRHP With BSE SME Business
  • English Partner Receives Business Mint NationWide Award for the – Best Online Education (English Course) 2023 Business
  • V6 Clinics Announces Partner-Led Expansion to 100 Clinics Across India by 2029 Business

Lincoln Pharmaceuticals Ltd enters elite league; Enters Rs. 1,000 crore plus market cap club

Posted on August 30, 2023 By

Company has set a target of achieving Rs. 750 crore revenue by FY26

Ahmedabad (Gujarat) [India], August 30: Lincoln Pharmaceuticals Limited, one of India’s leading healthcare companies has entered the elite league and Rs. 1,000 crore plus market capitalization companies club for the first time. Share price of the company hit a 52 week high of Rs. 513 per share on 28 August 2023 – gain of over 75% in a year’s time. Company aims to maintain healthy growth in revenue and margins in the coming years and has set a target of achieving Rs. 750 crore revenue by FY26 while maintaining its ‘Net Debt Free’ status.

For FY23, the company has reported its Best-ever results in a financial year with highest – Revenue, EBITDA and Net Profit. Company achieved a milestone of Rs. 500 crore plus revenue and Rs. 100 crore plus profit before tax for the first time in a financial year. During Q1FY24 also, company reported an excellent operational and financial performance with Y-o-Y growth of 26.7% in Net Profit, 21.4% growth in EBITDA and 10.3% growth in Total Income.

Company has successfully completed expansion of the Cephalosporin plant at Mehsana, Gujarat. Commercial production from this plant has started and the company started selling in the domestic markets with product registration under process for many countries for exports. The plant is expected to contribute sales of around Rs. 150 crore in next 3 years.

Company is also ranked among a very few companies to achieve a profit growth every single year from FY13 to FY23. It is among only 16 companies out of 4,200 plus listed companies in the Indian stock exchange to do so as per the analysis of Morningstar. During 10 years from FY13 to FY23, Company has delivered a robust CAGR of over 22% in Net profits, 19% plus in EBITDA and over 10% in Revenue.

Financial Performance – Lincoln Pharmaceuticals FY 13 to FY23

Rating agencies, CRISIL has upgraded its ratings on the company’s bank facilities to ‘CRISIL A/Stable and CRISIL A1’. ICRA too has reaffirmed the company’s long-term and short-term bank facilities to A and A1 respectively. The liquidity position of the company is on a strong foundation, supported by healthy cash accruals, no-term debt, and healthy return ratios.

Over the last few years, promoter group have gradually increased their stake in the company. Foreign institutional investors holding as on June 2023 stands at 1.74%. In the last one year, share price of the company has gained by over 75% – from Rs. 283.5 per share on 29 August 2022 to Rs. 4505 per share at close on 28 August 2023.

Company currently exports to 60 plus countries including East & West Africa, Central, North & Latin America and Southeast Asia. Company has recently started exports to Canada. TGA – Australia and EU GMP approvals will further strengthen the company’s presence and expand its network to 90 plus countries.

Lincoln Pharma has a state-of-the-art manufacturing facility unit at Khatraj in Ahmedabad, Gujarat, complying with stringent international quality and compliance norms and certified by EUGMP, TGA, WHO-GMP; ISO-9001:2015, ISO-14001:2015 and ISO-45001:2018. Company has developed 600 plus formulations in 15 therapeutic areas and has a strong product/brand portfolio in anti-infective, respiratory system, gynaecology, cardio & CNS, anti-bacterial, ant-diabetic, anti-malaria among others. Company has filed 25 plus patent applications and is awarded with seven patents.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: Funding Guru Subodh Bajpai Launches his Book Rise and Thrive Unleashing The Entrepreneurial Warrior”
Next Post: CSR Times and Indian Achievers’ Forum host the National Seminar on “Achieving SDG’s through CSR in developing Economies: Role of G20 Nations”

Related Posts

  • 950+ class owners benefited through GoI Intellectual Property Right (IPR) awareness program at Maharashtra Class Owners Association (MCOA) Teachers Felicitation Function Business
  • Subhash Kashyap’s, Web Hospitality, Provides Best Full-Scale Digital Marketing & SEO Solutions Business
  • Bada Brand: The Comprehensive Branding Application which Assists MSMEs to Go Digital Business
  • 12th National CSR summit “Role of CSR in Mission Viksit Bharat by 2047” held in New Delhi, Shri Nitin Gatkari Ji urges Community Engagement Business
  • Beyond Airport Bookstores: How TNS Is Changing the Face of Travel Retail in India Business
  • We Must Unite And Fight The Troubling Epidemic Of Neglected Tropical Diseases (Ndt’s) – Ms. Paris Keswani Business

Recent Posts

  • Ye Mahaveer Ka Panth Hai, Har Prani Me Sant Hai’ – Mahavir Nirvana Katha resonates at Bharat Mandapam
  • Unihealth Hospitals Limited Reports H1 FY27 Revenue of Rs 76.45 Crore; Positive Operating Cash Flow of Rs 23.83 Crore Amidst Significant Expansion Investments
  • Chhattisgarh CM Inaugurates PanIIT Alumni India’s Nursing Skill College Initiative in Jashpur
  • 8th International HKL Conference Begins at Gurdwara Bulandpuri Sahib; Flags of 116 Nations Hoisted to Promote Global Unity
  • Cash Ur Drive Marketing Reports Strong H1 FY27 Performance: EBITDA Rising 13% and Net Profit Growing 8% YoY

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Bollywood Actor and Director Arbaaz Khan tie up with Fashion Brand Rohini Sethi Haute Couture for an exclusive Photoshoot Business
  • CultureX – to disrupt Gujarat’s influencer Economy via exclusive licensing of its Influencer Marketplace Software to a leading state partner Business
  • Rama Steel Tubes Ltd. Announces Excellent Results, Board to Meet to consider Bonus Issue Business
  • India can guide COP10 to include science & evidence-based policy to solve for tobacco diseases Health
  • Designer NAVKIYA G Brings Vibrant Designs to Life at India Kids Fashion Week Season 11, Delhi Lifestyle
  • Liquide’s Draws 1,500+ Seasoned Traders to Conclave 5.0 as AI Reshapes India’s Trading Landscape Business
  • Aakash BYJU’S Launches its Biggest and Most Awaited National Talent Hunt Exam, ANTHE 2023 Education
  • Higher Education Conclave, Chandigarh, to happen on 13th August this Year at Hyatt Press Release

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme